A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer
Titel:
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer
Auteur:
Novello, S. Besse, B. Felip, E. Barlesi, F. Mazieres, J. Zalcman, G. von Pawel, J. Reck, M. Cappuzzo, F. Ferry, D. Carcereny, E. Santoro, A. Garcia-Ribas, I. Scagliotti, G. Soria, J.-C.